Edurant (Rilpivirine) is an antiviral medication that is used to treat HIV and AIDS. Rilpivirine belongs to a class of medications called non-nucleoside reverse transcriptase inhibitors (NNRTIs). Reverse transcriptase is an enzyme that is needed by HIV for reproduction. Rilpivirine blocks the action of this enzyme. This medication must be used in combination with other medications to treat HIV infections.
The brand Edurant comes from Canada and is manufactured by Janssen-Ortho. It is available in the strength of 25mg tablet.
Common side effects include:
• Dizziness, headache;
• Mild skin rash;
• Stomach pain, nausea;
• Unusual dreams
Serious side effects include:
• Changes in the shape or distribution of body fat;
• Cough with yellow or green mucus;
• Pain in the chest, wheezing, feeling short of breath;
• Severe depression
You should not take Edurant if you are allergic to Rilpivirine or any of the other ingredients in the medication. The recommended dose of Rilpivirine is one 25mg tablet taken once daily. This medication must be taken with a meal to allow your body to absorb as much of the medication as possible. Edurant is not expected to harm an unborn baby, but HIV can be passed on to your baby if you are not properly treated during pregnancy. Women with HIV and AIDS should not breast feed a baby. HIV virus may pass on to the baby through breast milk. There may be an interaction with Rilpivirine and other medications such as antacids, corticosteroids, diuretics, grapefruit or grapefruit juice, methadone, etc.